Experiment summary for ENCSR000EMV
doi:10.17989/ENCSR000EMV
Summary
- Status
- released
- Assay
- DNase-seq
- Biosample summary
- Homo sapiens cardiac myoblast originated from H7 treated with 10 ng/mL Bone morphogenetic protein 4 for 9 days, 5 ng/mL Fibroblast growth factor 2 for 9 days, 6 ng/mL Activin A for 9 days
- Biosample Type
- in vitro differentiated cells
- Replication type
- unreplicated
- Description
- DNase-seq on human H7-hESC differentiated for 9 days
- Treatments
- 10 ng/mL Bone morphogenetic protein 4 (UniProtKB:P12644) for 9 days, 5 ng/mL Fibroblast growth factor 2 (UniProtKB:P09038) for 9 days, 6 ng/mL Activin A (CHEBI:81351) for 9 days
- Nucleic acid type
- DNA
- Fragmentation methods
- see document
Attribution
ENCODE2 project
- Lab
- John Stamatoyannopoulos, UW
- Award
- U54HG004592 (John Stamatoyannopoulos, UW)
- Project
- ENCODE
- External resources
- Date submitted
- January 11, 2011
- Date released
- July 23, 2012
- Treatment Time Series
- ENCSR167QXA
- Reference Epigenome
- ENCSR472YCH
- Annotation (gkmsvm-model)
- Tags
- Registry of cCREs
Encyclopedia Integration
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Library |
|---|---|---|---|---|
| 1 | 1 | Homo sapiens female embryo cardiac myoblast in vitro differentiated cells originated from H7 treated with 10 ng/mL Bone morphogenetic protein 4 for 9 days, 5 ng/mL Fibroblast growth factor 2 for 9 days, 6 ng/mL Activin A for 9 days | ENCBS297AAA | ENCLB443ZZZ |